-+ 0.00%
-+ 0.00%
-+ 0.00%
858 THERAPEUTICS ANNOUNCES FDA FAST TRACK DESIGNATION FOR PARG INHIBITOR ETX-19477 FOR THE TREATMENT OF PATIENTS WITH BRCA-MUTATED, HR+/HER2- UNRESECTABLE OR METASTATIC BREAST CANCER
Share

Please log in to view news

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending